Sun Pharma to consider ₹15,000 crore NCD issue
Sun Pharma to consider ₹15,000 crore NCD issue. The board will meet on October 12 to approve the issuance. The move aims to strengthen the company’s capital structure and fund future growth initiatives. ₹15,000 crore is a significant raise, signaling confidence in expansion plans.
📊 STOCKS: $SUNPHARMA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Funding
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.